Login to Your Account

Aelix Therapeutics raises $13M for therapeutic HIV vaccine

By Cormac Sheridan
Staff Writer

Tuesday, January 12, 2016

DUBLIN – The latest contender to emerge from Spain's fledgling biotech sector is Aelix Therapeutics SL, which has raised €11.5 (US$12.6 million) in a series A round to fund clinical development of a therapeutic vaccine for HIV infection.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription